Authors

Manmeet Ahluwalia, Miami Cancer InstituteFollow

Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients

Publication Date

12-2022

Content Type

Article

PubMed ID:

36255215

Additional Authors:

Additional authors and institutional affiliations

Citation

Lehrer, E. J., Gurewitz, J., Bernstein, K., Kondziolka, D., Fakhoury, K. R., Rusthoven, C. G., Niranjan, A., Wei, Z., Lunsford, L. D., Malouff, T. D., Ruiz-Garcia, H., Peterson, J. L., Bonney, P., Hwang, L., Yu, C., Zada, G., Deibert, C. P., Prasad, R. N., Raval, R. R., Palmer, J. D., … Trifiletti, D. M. (2022). Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients. Neurosurgery, 91(6), 872–882. https://doi.org/10.1227/neu.0000000000002127